Novavax Inc (NVAX)

[JoeForkeyBolo]

Link to video of FDA Vaccine and Related Biological Products Advisory Committee Meeting held on June 5, 2024.

Novavax Chief Medical Officer, Dr. Robert Walker, begins his 18-minute presentation to the committee at 3:21:15 in the video, where he provides the data supporting Novavax's decision to begin manufacturing of the JN.1 vaccine, and why this will be effective for KP.2/KP.3 and all sub variants of the JN.1 lineage. A lot of technical detail is given, but it's worth it to muddle through because by the end of the presentation it is clear, even to the layman, that their JN.1 approach and recommendation to the committee was effective in helping steer the committee to identifying JN.1 as their recommendation. Overall an excellent presentation by Novavax.